India's pharmaceutical exports are projected to reach USD 65 billion by 2030, with a target of USD 350 billion by 2047, ...

India's pharma exports are expected to double to USD 65 billion by 2030 and touch USD 350 billion in value terms by 2047, ...

Let’s accept the fact that we are likely to be dealing with volatility for the next four years. Both in the real world and in ...

Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic drugs.

Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...

Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided ...

Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...

The three-day conference will address crucial topics related to pharmaceutical regulation, impurity assessment, sustainability, and future governance of the IMWP.

Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasised the importance of regulatory harmonisation in ensuring patient safety and ...

The Union Budget 2025 presents an opportunity to propel this sector toward innovation, self-reliance, and global ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

Weight loss drugs, which took the US market by storm, are looking to be a big opportunity for drug makers in India. Several ...